Octreotide is a synthetic hormone used to treat conditions where the body overproduces certain hormones or digestive substances. It has three FDA-approved uses: acromegaly (excess growth hormone), carcinoid tumors that cause severe flushing and diarrhea, and a rare type of pancreatic tumor called a VIPoma. It also sees widespread use in hospitals for gastrointestinal bleeding and other off-label purposes.
How Octreotide Works
Your body naturally produces a hormone called somatostatin, which acts as a brake on other hormones. Octreotide is a lab-made version of somatostatin, but it lasts much longer in the body and is more potent at suppressing growth hormone, insulin, and glucagon. It works by binding to specific receptors on cells, which lowers the activity of signaling molecules inside those cells. The practical result is that hormone-producing tissues slow down or stop releasing their products into the bloodstream.
Acromegaly
Acromegaly happens when the pituitary gland produces too much growth hormone, usually because of a benign tumor. This leads to gradual enlargement of the hands, feet, and facial features, along with joint pain, fatigue, and metabolic problems. Surgery to remove the tumor is the first-line treatment, but when surgery doesn’t fully work or isn’t an option, octreotide is one of the primary medications used to bring hormone levels down.
After a year of treatment with the long-acting form of octreotide, about 57% of patients see their growth hormone drop to target levels and 67% achieve normal levels of IGF-1, a related hormone that drives many of acromegaly’s symptoms. When octreotide is used as a first-line therapy (before or instead of surgery), the numbers are slightly better: roughly 70% reach normal growth hormone levels and 68% normalize IGF-1. These improvements tend to increase the longer treatment continues.
Carcinoid Syndrome
Carcinoid tumors are slow-growing cancers, most commonly found in the gut, that can release large amounts of hormones like serotonin into the bloodstream. When that happens, the result is carcinoid syndrome: episodes of intense flushing, severe diarrhea, wheezing, and sometimes heart problems. These symptoms can be debilitating.
Octreotide is the cornerstone treatment for controlling these symptoms. A meta-analysis pooling data from multiple studies found that about 67% of patients experienced a partial or complete response in diarrhea, and 68% saw meaningful improvement in flushing episodes. It doesn’t cure the underlying cancer, but for many patients it makes daily life manageable again.
VIPomas
VIPomas are rare tumors, typically in the pancreas, that secrete vasoactive intestinal peptide. This causes profuse, watery diarrhea that can lead to dangerous dehydration and electrolyte imbalances. Octreotide suppresses the excess hormone output from these tumors and is FDA-approved specifically for controlling the diarrhea they cause.
Gastrointestinal Bleeding
One of the most common uses of octreotide in hospitals is for acute bleeding from varices, which are swollen veins in the esophagus or stomach that develop in people with liver disease. Octreotide reduces blood flow to the digestive tract, helping to slow or stop the bleeding. In this setting it’s given intravenously as a bolus followed by a continuous drip, typically continued for one to five days alongside other treatments like endoscopy.
Sulfonylurea Overdose
When someone overdoses on sulfonylurea diabetes medications, their blood sugar can drop dangerously low because these drugs force the pancreas to keep releasing insulin. Standard treatment with sugar or IV glucose often provides only temporary relief because the drug keeps pushing out more insulin. Octreotide directly suppresses insulin release from the pancreas, making it an effective antidote. Most patients need only one to three doses given by injection to stabilize their blood sugar while the sulfonylurea clears the body.
Dumping Syndrome
Some people who have had stomach surgery develop dumping syndrome, where food moves too quickly from the stomach into the small intestine. This causes nausea, cramping, diarrhea, dizziness, and blood sugar swings shortly after eating. Dietary changes are the first step, but when those aren’t enough, octreotide can help. In a study of 30 patients with dumping syndrome that hadn’t responded to dietary changes, octreotide cut symptom severity scores nearly in half. The long-acting monthly injection was preferred by patients, with 83% rating it effective compared to 52% for the daily injection form. Quality of life improved significantly alongside the symptom scores.
Short-Acting vs. Long-Acting Forms
Octreotide comes in two formulations that work the same way but differ substantially in how often you need them. The short-acting form is given by injection under the skin, and its effects last up to 12 hours depending on the condition being treated. That means multiple injections per day, which is practical for short-term hospital use but burdensome for long-term management.
The long-acting version, known as octreotide LAR, is injected into the muscle of the buttock once every four weeks. It slowly releases the medication over the month, providing much more stable drug levels. With the short-acting form, blood levels of octreotide swing by 163% to 209% between peaks and troughs over a day. The long-acting version narrows that swing to 44% to 68%, meaning more consistent symptom control with far fewer injections.
Side Effects to Expect
The most common side effects involve the digestive system: nausea, abdominal discomfort, bloating, and loose stools, particularly when starting treatment. These tend to improve over time as the body adjusts.
The more significant long-term concern is gallbladder problems. Octreotide slows the release of bile from the gallbladder, which allows sludge and gallstones to form. This is well documented in patients on long-term therapy and is something doctors routinely monitor with periodic ultrasounds. In some cases, gallbladder inflammation develops and requires treatment.
Because octreotide suppresses multiple hormones, it can also affect blood sugar regulation. It inhibits insulin but also suppresses the counter-regulatory hormones that raise blood sugar, so the net effect varies. Some patients develop mildly elevated blood sugar, while others, particularly those with diabetes, may need adjustments to their existing medications. Thyroid function can also be affected over time with long-term use.